News

The 4th ICN symposium was successful held in Istanbul, Turkey on 13 September 2018 by one the founding members, Center of Excellence for Clinical Research of University of Istanbul. The symposium highlighted in investigator-initiated clinical research and data sharing. Representatives of ICN shared their local laws, regulations, as well as institutional policies relating to data sharing across countries.

Followed by the symposium, the 4th annual steering board meeting was successfully held at a beautiful off-site venue of Istanbul University on 14 September 2018. Representative of HKU-CTC was invited to do an opening remark by sharing its insights, experiences and current interactions with partners in Mainland China. Various topics, including overview of ICN memberships and operations team, legal and governance aspects, future ICN strategies and ICN outlooks were discussed. In addition, Dr. Thomas Hiemstra of Cambridge Clinical Trials Unit was elected as the new ICN Vice-Chairman during the meeting.

In a recent survey “2017 Best 50 Hospitals in the Guangdong-Hong Kong-Macau Greater Bay Area” conducted by Asclepious Healthcare consultant, Queen Mary Hospital (“QMH”), a teaching hospital of The University of Hong Kong (“HKU”), ranked first amongst the rest! The ranking was carried out among comprehensive hospitals and traditional Chinese medicine hospitals in nine cities and two special administrative regions in the Greater Bay Area. The assessment criteria of the survey covered four aspects, including medical expertise, resources, hospital operation and academic impact. QMH’s application of advanced medical technologies and its active participation in research are important factors for QMH to gain its first place. In addition, QMH is also ranked a top-3 hospital in the Chinese Community in Asclepious survey “2017 Best 100 hospitals in the Chinese Community”.

HKU-CTC has a long history of collaboration with QMH. Since our establishment in 1998, we have been supporting the professional research teams of HKU and QMH in managing their clinical research projects in QMH. With this encouraging recognition as the best hospital in the area, HKU-CTC will continue to strive in advancing human healthcare by promoting, attracting and facilitating clinical studies at the highest professional standards.

http://hd.stheadline.com/news/realtime/hk/1264107/
(From "Headline Daily")

Everyone of us should have taken generic drugs before, but how much do you know about this. HKU-CTC produced a short video named ‘What is Generic Drugs?’ to introduce the concept of generic drugs and bioequivalent study to the general public, and was aired on Facebook on December 30, 2017. Dr. Tommy Cheung (Deputy Medical Director, HKU Phase 1 Centre) together with our lovely kids jointly talk about a story on generic drugs in this video.

Dr. Hong and Ceci are thrilled to announce that the Phase 1 Novel Drug Clinical Trial conducted at HKU Phase 1 Centre was approved by the China Food and Drug Administration (CFDA)! It proves that the contribution of healthy volunteers are rewarding!

A Phase 1 clinical trial on novel hepatitis C drug was completed at HKU Phase 1 Clinical Trials Centre in 2015. It provided important data on drug metabolism of Chinese people which expedited the completion time of clinical studies in China. The drug could finally be approved by CFDA in April 2018.

The drug received its first global approval from the U.S. Food and Drug Administration (FDA) in January 2016 and subsequently its registration in Hong Kong from the Department of Healthy in January 2018. It took only merely 2 years for the drug to obtain the approval to register in China after its first global approval. More patients could benefit from it and the result was truly encouraging to all.

We would like to thank all healthy volunteers who participated in this clinical study for your precious time and contribution in supporting the drug discovery!

U.S. Food and Drug Administration: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm483828.htm
Department of Health, Hong Kong: http://www.drugoffice.gov.hk/eps/drug/productDetail/en/consumer/98948

Please like and share our Facebook link to your family members, friends and colleagues who are interested in healthcare information and medical research. Stay tuned to our posts and we are here to answer your inquiries on Facebook!

https://www.facebook.com/hkuctc/